Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Cash from Operations (2023 - 2025)

Historic Cash from Operations for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $28.2 million.

  • Guardian Pharmacy Services' Cash from Operations rose 140170.98% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.0 million, marking a year-over-year increase of 7536.32%. This contributed to the annual value of $58.0 million for FY2024, which is 1815.76% down from last year.
  • According to the latest figures from Q3 2025, Guardian Pharmacy Services' Cash from Operations is $28.2 million, which was up 140170.98% from $19.9 million recorded in Q2 2025.
  • Over the past 5 years, Guardian Pharmacy Services' Cash from Operations peaked at $29.1 million during Q2 2024, and registered a low of -$2.2 million during Q3 2024.
  • Moreover, its 3-year median value for Cash from Operations was $18.7 million (2025), whereas its average is $17.3 million.
  • Over the last 5 years, Guardian Pharmacy Services' Cash from Operations had its largest YoY gain of 140170.98% in 2025, and its largest YoY loss of 3156.9% in 2025.
  • Over the past 3 years, Guardian Pharmacy Services' Cash from Operations (Quarter) stood at $14.6 million in 2023, then soared by 53.48% to $22.3 million in 2024, then grew by 26.11% to $28.2 million in 2025.
  • Its Cash from Operations was $28.2 million in Q3 2025, compared to $19.9 million in Q2 2025 and $17.6 million in Q1 2025.